http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (Medical Xpress) -- Treating asthma with leukotriene-modifying agents does not pose an increased risk of suicide in children, according to new research at the University of Illinois at Chicago College of Pharmacy. http://medicalxpress.com/news/2012-07-link-asthma-drugs-suicide.html Immunology Wed, 04 Jul 2012 06:48:29 EST news260603290 Australian researchers are calling for the open sharing of clinical trial data in the medical research community, saying it would be instrumental in eliminating bottlenecks and duplication, and lead to faster and more trustworthy evidence for many of our most pressing health problems. http://medicalxpress.com/news/2012-05-hacked.html Other Wed, 02 May 2012 14:50:02 EST news255187742 Adding trastuzumab (trade name Herceptin) to the treatment offered to women who have HER2-positive breast cancer, significantly increases the chance of life being prolonged, and reduces the chance of tumours reappearing once therapy stops. This is important, because about one-fifth of women who develop early breast cancer have HER2-positive tumours that, if untreated, are associated with a worse outlook than HER2-negative tumours. At the same time, however, women given trastuzumab have a higher risk of experiencing problems with their heart. These findings are the key conclusions of a systematic review published in The Cochrane Library. http://medicalxpress.com/news/2012-04-trastuzumab-survival-benefits-heart-women.html Cancer Tue, 17 Apr 2012 19:00:01 EST news253891447 In 2004, concerns about antidepressant drugs increasing suicidal thoughts and behaviors in young patients prompted the FDA to issue a rare "black box warning." Now, a new analysis of clinical trial data finds that treatment with the antidepressant fluoxetine did not increase — or decrease — suicidality in children compared to placebo treatment. http://medicalxpress.com/news/2012-02-antidepressant-suicide-link-youths-absent-analysis.html Psychology & Psychiatry Mon, 06 Feb 2012 16:00:14 EST news247755822 (AP) -- Regulators on Friday approved Regeneron Pharmaceuticals Inc.'s drug Eylea, an injection designed to treat a common cause of blindness in older people. http://medicalxpress.com/news/2011-11-fda-regeneron-eye-eylea.html Medications Sat, 19 Nov 2011 11:25:44 EST news240924324 Genetic analysis of the tumors from patients with advanced melanoma can clue researchers in to how well patients will respond to a therapy that targets the growth-promoting protein called BRAF, a researcher from the Perelman School of Medicine at the University of Pennsylvania will report on Monday, June 6 at the annual meeting of the American Society of Clinical Oncology. Looking outside of the BRAF gene, the researchers found loss of the tumor suppressor gene PTEN also appears to be associated with patient response to GSK436, which could help guide researchers to even more personalized approaches to melanoma therapy. http://medicalxpress.com/news/2011-06-genes-response-braf-inhibitors-advanced.html Cancer Wed, 01 Jun 2011 15:07:15 EST news226159402